Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alpharadin dose-finding in hormone-refractory prostate cancer
NCT00337155Phase 2Completed
- Sponsor
- Bayer
- Start
- May 2006
- Primary completion
- Dec 2008
- Modality
- Radiopharmaceutical
- Countries
- 1
01
Overview
A Phase 2 trial of radium-223 dichloride in prostate cancer (PCa), sponsored by Bayer. Started May 2006; status: completed.
02
Drugs
radium-223 dichloride
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00337155.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00337155.